Copyright
©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2671-2675
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2671
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2671
Table 1 Expression of HBxAg, Fas and FasL in HCC (n = 50)
| Expression | HBxAg (%) | Fas(%) | FasL(%) |
| - | 2(4) | 8(16) | 1(2) |
| + | 5(10) | 9(18) | 4(8) |
| ++ | 11(22) | 9(18) | 12(24) |
| +++ | 32(64) | 24(48) | 33(66) |
Table 2 Serum levels of sFas and sFasL in patients with HCC and Cirrhosis (μg·L-1)
Table 3 Positive rates of HBV X gene, HBsAg and HBeAg in HCC and cirrhotic patients (%)
| Group | HBV X gene | HBsAg | HBeAg |
| HCC | 32 | 86 | 34 |
| Cirrhosis | 46 | 82 | 38 |
- Citation: Wang XZ, Chen XC, Chen YX, Zhang LJ, Li D, Chen FL, Chen ZX, Chen HY, Tao QM. Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system. World J Gastroenterol 2003; 9(12): 2671-2675
- URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i12.2671